- Home
- Pathology Industry
- Liver Disease Market and Forecasts, May 2013
Industries
- Pathology (524)
- Drug and Medication (247)
- Meat and Poultry (69)
- Agriculture (63)
- Fish and Seafood (53)
-
- Fruit and Vegetable (53)
- Food (46)
- Water Distribution and Treatment (46)
- Biotechnology (45)
- Energy & Environment (36)
- Biological Therapy (32)
- Vitamin and Supplement (31)
- Dairy Products and Egg (27)
- Pharmaceutical (26)
- Blood Supply, Tissue Banking and Transplantation (23)
- Managed Care (22)
- Medical Facility (22)
- Tobacco (21)
- Beverage (20)
- Healthcare (19)
Top countries
- United States (669)
- India (165)
- World (142)
- Canada (97)
- China (82)
-
- Europe (81)
- Ireland (75)
- Australia (70)
- United Kingdom (55)
- Japan (32)
- Germany (24)
- Nigeria (21)
- South Korea (21)
- Russian Federation (19)
- Africa (17)
- Malaysia (16)
- Thailand (16)
- Egypt (14)
- Philippines (14)
- Pakistan (13)
Publication dates
All regions
-
- Azerbaijan (3)
- Bangladesh (5)
- Bhutan (1)
- Cambodia (2)
- China (82)
- Georgia (6)
- India (165)
- Indonesia (6)
- Iran (6)
- Iraq (1)
- Israel (4)
- Japan (32)
- Jordan (2)
- Kuwait (1)
- Malaysia (16)
- Mongolia (1)
- Nepal (3)
- Pakistan (13)
- Philippines (14)
- Saudi Arabia (3)
- Singapore (5)
- South Korea (21)
- Sri Lanka (2)
- Taiwan (6)
- Thailand (16)
- Turkey (5)
- Vietnam (4)
-
- Austria (1)
- Belgium (3)
- Bulgaria (2)
- Croatia (1)
- Cyprus (2)
- Czech Republic (5)
- Denmark (12)
- Estonia (1)
- Finland (9)
- France (13)
- Germany (24)
- Greece (2)
- Hungary (2)
- Iceland (2)
- Ireland (75)
- Italy (12)
- Lithuania (1)
- Luxembourg (2)
- Macedonia (3)
- Malta (1)
- Moldova, Republic Of (2)
- Netherlands (7)
- Norway (5)
- Poland (3)
- Portugal (2)
- Russian Federation (19)
- Serbia and Montenegro (2)
- Slovenia (1)
- Spain (12)
- Sweden (7)
- Switzerland (6)
- Ukraine (1)
- United Kingdom (55)
-
- Australia (70)
- Austria (1)
- Belgium (3)
- Canada (97)
- Chile (6)
- Czech Republic (5)
- Denmark (12)
- Estonia (1)
- Finland (9)
- France (13)
- Germany (24)
- Greece (2)
- Hungary (2)
- Iceland (2)
- Ireland (75)
- Israel (4)
- Italy (12)
- Japan (32)
- Luxembourg (2)
- Mexico (4)
- Netherlands (7)
- New Zealand (13)
- Norway (5)
- Poland (3)
- Portugal (2)
- Slovenia (1)
- South Korea (21)
- Spain (12)
- Sweden (7)
- Switzerland (6)
- Turkey (5)
- United Kingdom (55)
- United States (669)
data types
- All
- Industry Data
- Company Data (1 634)
- Country Data (534)
Liver Disease Market and Forecasts, May 2013
You might be interested in: hepatitis c, hepatitis b, clinical trial, more »
industry reports
country reports
Liver Disease Sector (liver disease, hepatitis) in The United States
- Industry report
- November 2011
- 17 pages
- by Corporation
... Is caused by fatty liver disease, viral hepatitis, iron overload and excess alcohol consumption Viral hepatitis affects 170m people world wide If left untreated, liver fibrosis can progress to liver ...
- Industries: Pathology
- Countries: United States
Liver Disease Market (liver disease, hepatitis) in The United States
- Industry report
- November 2011
- 17 pages
... To a liver biopsy assessment of fat Hepafat scan Demonstrated higher levels of sensitivity and specificity than any other published method Resonance health is now seeking international patent ...
- Industries: Pathology
- Countries: United States
Liver Disease Market Overview (liver disease, hepatitis c)
- Industry report
- February 2012
- 20 pages
... Study of participants with advanced hepatitis c-related liver disease, regular coffee consumption was associated with lower rates of disease progression. - Hepatology 2009 a reliable tool ...
- Industries: Pathology
Liver Disease Sector in The United States
- Industry report
- July 2011
- 50 pages
... And steatohepatitis (nash), is the most common liver disease with increasing incidence. Nafld without cirrhosis is rapidly evolving as a significant risk factor for primary hepatocellular carcinoma (hcc ...
- Industries: Pathology
- Countries: United States
The European Liver Disease Market : Innovation and Technology Trends (liver disease, gastric cancer, inflammatory bowel disease)
- Industry report
- September 2012
- 13 pages
... To digestive and liver diseases In europe ,one in four children is overweight and some are underweight image title this is example caption copy and has been set up as the default text box style ...
U.S. Liver Disease Sector (liver disease, diabete, coronary artery disease)
- Industry report
- January 2011
- 20 pages
... Nafld nash/pn as an indication for lt 6/28/2012 7 nash and cryptogenic cirrhosis Nash and cryptogenic cirrhosis share features of metabolic syndrome (caldwell, 1999) Nash develops following liver ...
- Industries: Pathology
- Countries: United States
Liver Disease Market (liver disease, hepatitis c, hepatitis b) in The United States and Canada
- Industry report
- February 2011
- 30 pages
... And applicants. As an example: questions... Is there liver disease What is the severity of the disease What is the mortality risk Is there liver disease Applicant reported Abnormal liver enzyme ...
- Industries: Pathology
- Countries: United States, Canada
The Australian Influenza Sector (influenza, liver disease, carcinoma)
- Industry report
- May 2012
- 42 pages
- by Corporation
... Not easily tolerated by patients 9 polyclonal antibodies advantageous in combating infectious diseases 8 monoclonal antibodies strain specific 9 oral administration 9 oral administration 9 rapid ...
Diabete : Innovation and Technology Trends (diabete, liver disease)
- Industry report
- October 2012
- 16 pages
- by Non Governmental Organization (NGO)
... Enrollment of ckd patients in sprint systolic blood pressure intervention trial (sprint) test if reducing systolic bp below current recommended level reduces cardiovascular disease (cvd) risk plans ...
- Industries: Pathology
Hepatitis C Market (hepatitis c, liver disease) in Australia and The United States
- Industry report
- March 2012
- 3 pages
- by Research Paper
... Of the number of people living with hepatitis c infection by stage of liver disease, as well as self-reported health status. Crucially, the strategy also aims to increase access to clinical care, which ...
- Industries: Pathology
- Countries: Australia, United States, World
» Read our Company Profiles
3 Companies for Liver DiseaseReportlinker.com © Copyright 2013. All rights reserved.
